Peer-reviewedCC BYClinical and Translational Medicine
Toward selective amyloid clearance through rational nanomedicine design
- 1Department of Cardiology Tianjin Union Medical Centre The First Affiliated Hospital of Nankai UniversityTianjin China
- 2Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences Academy for Advanced Interdisciplinary Studies Nankai University Tianjin China
Related
- Spatial patterns of amyloid clearance after donanemab: A preliminary 12‐month real‐world amyloid PET study in Japanese patients with early Alzheimer's disease
- Regional amyloid-PET clearance dynamics and anti-Aβ monoclonal antibody therapy: a preliminary real-world study.
- Apolipoprotein E lipidation, rather than isoform identity, determines amyloid-β binding and astrocyte clearance
- Reversing liver sinusoidal endothelial aging restores clearance of amyloid-beta and LDL
- Mechanochemically Programmed, Oligomer‐Selective Amyloid Assembly via Axial Rotation
BibTeX
@article{qi2026toward,
title = {{Toward selective amyloid clearance through rational nanomedicine design}},
author = {Tianyi Qi and Jie Zhuang and Yuejuan Cao and Xinglu Huang},
journal = {Clinical and Translational Medicine},
year = {2026},
month = oct,
doi = {10.1002/ctm2.70859},
url = {https://doi.org/10.1002/ctm2.70859},
note = {CC BY},
}
RIS
TY - JOUR
TI - Toward selective amyloid clearance through rational nanomedicine design
AU - Tianyi Qi
AU - Jie Zhuang
AU - Yuejuan Cao
AU - Xinglu Huang
PY - 2026
DA - 2026/10/26
JO - Clinical and Translational Medicine
DO - 10.1002/ctm2.70859
UR - https://doi.org/10.1002/ctm2.70859
SN - 2001-1326
ER -